Health care stocks were edging higher premarket Wednesday. The iShares Biotechnology ETF (IBB) was up by 0.64% while the Health Care SPDR (XLV) was 0.02%...
Leap Therapeutics (LPTX) said late on Tuesday the combination of anti-Dickkopf-1, or DKN-01, with tislelizumab "continues to demonstrate encouraging...
...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
| Address | 47 Thorndike Street Cambridge, Massachusetts 02141 |
| Phone | +1.617.714.0360 |
| Number of Employees | 25 |
| Recent SEC Filing | 01/18/2022 8-K |
| President, CEO, CFO, Secretary & Treasurer | Doug E. Onsi |
| Chief Operating Officer | Augustine J. Lawlor |
| Chief Medical Officer | Cynthia Sirard |
| Head-Research | Michael Haas |
| Price Open | $2.26 |
| Previous Close | $2.39 |
| 52 Week Range | $1.33 - 4.17 |
| Market Capitalization | $186.4 M |
| Shares Outstanding | 88.3 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 03/11/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$0.47 |
| Beta vs. S&P 500 | N/A |
| Revenue | $0.00 |
| Net Profit Margin | -2,433.93% |
| Return on Equity | -63.02% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
